High-Density Lipoprotein Subclasses, Coronary Artery Disease, and Cardiovascular Mortality. 2017

Günther Silbernagel, and Philipp Pagel, and Volker Pfahlert, and Bernd Genser, and Hubert Scharnagl, and Marcus E Kleber, and Graciela Delgado, and Haruna Ohrui, and Andreas Ritsch, and Tanja B Grammer, and Wolfgang Koenig, and Winfried März
Division of Angiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria; guenther.silbernagel@yahoo.com.

BACKGROUND The inverse relationship between HDL cholesterol and cardiovascular mortality is weakened in coronary artery disease (CAD). We aimed to investigate the associations of HDL particle concentrations with cardiovascular mortality and the impact of CAD on these associations. We also sought to comparatively evaluate HDL cholesterol and HDL particle concentrations in predicting cardiovascular mortality. METHODS Total and subclass HDL particle concentrations were measured by nuclear magnetic resonance spectroscopy in 2290 participants of the LUdwigshafen RIsk and Cardiovascular Health study referred for coronary angiography. The participants were prospectively followed over a median (interquartile range) duration of 10.0 (6.1-10.6) years. RESULTS The mean (SD) age of the participants (1575 males, 715 females) was 62.9 (10.4) years; body mass index, 27.6 (4.1) kg/m2; HDL cholesterol, 39 (11) mg/dL [1 (0.29) mmol/L]; and total HDL particle concentration, 24.1 (5.8) μmol/L. Of the participants, 434 died from cardiovascular diseases. In multivariate analyses, tertiles of total HDL particle concentrations were inversely related to cardiovascular mortality (hazard ratio for third vs first tertile = 0.55, P < 0.001). This association was primarily mediated by small HDL particles (P < 0.001). Adding total or small HDL particle concentrations rather than HDL cholesterol to multivariate prediction models improved performance metrics for cardiovascular mortality. The presence of CAD had no impact on the associations between HDL particle concentrations and cardiovascular mortality. CONCLUSIONS High HDL particle concentration is consistently and independently of CAD associated with decreased cardiovascular mortality. Whether the inverse relationship between HDL particle concentration and cardiovascular mortality may be translated into novel therapies is under investigation.

UI MeSH Term Description Entries
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Günther Silbernagel, and Philipp Pagel, and Volker Pfahlert, and Bernd Genser, and Hubert Scharnagl, and Marcus E Kleber, and Graciela Delgado, and Haruna Ohrui, and Andreas Ritsch, and Tanja B Grammer, and Wolfgang Koenig, and Winfried März
December 2013, European heart journal,
Günther Silbernagel, and Philipp Pagel, and Volker Pfahlert, and Bernd Genser, and Hubert Scharnagl, and Marcus E Kleber, and Graciela Delgado, and Haruna Ohrui, and Andreas Ritsch, and Tanja B Grammer, and Wolfgang Koenig, and Winfried März
January 2012, Journal of clinical lipidology,
Günther Silbernagel, and Philipp Pagel, and Volker Pfahlert, and Bernd Genser, and Hubert Scharnagl, and Marcus E Kleber, and Graciela Delgado, and Haruna Ohrui, and Andreas Ritsch, and Tanja B Grammer, and Wolfgang Koenig, and Winfried März
September 1990, The American journal of cardiology,
Günther Silbernagel, and Philipp Pagel, and Volker Pfahlert, and Bernd Genser, and Hubert Scharnagl, and Marcus E Kleber, and Graciela Delgado, and Haruna Ohrui, and Andreas Ritsch, and Tanja B Grammer, and Wolfgang Koenig, and Winfried März
May 1981, Occupational health & safety (Waco, Tex.),
Günther Silbernagel, and Philipp Pagel, and Volker Pfahlert, and Bernd Genser, and Hubert Scharnagl, and Marcus E Kleber, and Graciela Delgado, and Haruna Ohrui, and Andreas Ritsch, and Tanja B Grammer, and Wolfgang Koenig, and Winfried März
June 1994, Current opinion in lipidology,
Günther Silbernagel, and Philipp Pagel, and Volker Pfahlert, and Bernd Genser, and Hubert Scharnagl, and Marcus E Kleber, and Graciela Delgado, and Haruna Ohrui, and Andreas Ritsch, and Tanja B Grammer, and Wolfgang Koenig, and Winfried März
June 2014, The American journal of the medical sciences,
Günther Silbernagel, and Philipp Pagel, and Volker Pfahlert, and Bernd Genser, and Hubert Scharnagl, and Marcus E Kleber, and Graciela Delgado, and Haruna Ohrui, and Andreas Ritsch, and Tanja B Grammer, and Wolfgang Koenig, and Winfried März
January 2007, Medicinski arhiv,
Günther Silbernagel, and Philipp Pagel, and Volker Pfahlert, and Bernd Genser, and Hubert Scharnagl, and Marcus E Kleber, and Graciela Delgado, and Haruna Ohrui, and Andreas Ritsch, and Tanja B Grammer, and Wolfgang Koenig, and Winfried März
June 1997, Indian journal of biochemistry & biophysics,
Günther Silbernagel, and Philipp Pagel, and Volker Pfahlert, and Bernd Genser, and Hubert Scharnagl, and Marcus E Kleber, and Graciela Delgado, and Haruna Ohrui, and Andreas Ritsch, and Tanja B Grammer, and Wolfgang Koenig, and Winfried März
September 2004, Current atherosclerosis reports,
Günther Silbernagel, and Philipp Pagel, and Volker Pfahlert, and Bernd Genser, and Hubert Scharnagl, and Marcus E Kleber, and Graciela Delgado, and Haruna Ohrui, and Andreas Ritsch, and Tanja B Grammer, and Wolfgang Koenig, and Winfried März
June 2000, Molecular and cellular biochemistry,
Copied contents to your clipboard!